nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethosuximide—Gastrointestinal symptom NOS—Metformin—polycystic ovary syndrome	0.0413	0.112	CcSEcCtD
Ethosuximide—Upset stomach—Metformin—polycystic ovary syndrome	0.037	0.101	CcSEcCtD
Ethosuximide—Lethargy—Metformin—polycystic ovary syndrome	0.018	0.0488	CcSEcCtD
Ethosuximide—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.0161	0.0437	CcSEcCtD
Ethosuximide—Breast disorder—Metformin—polycystic ovary syndrome	0.0159	0.0432	CcSEcCtD
Ethosuximide—Cramp muscle—Metformin—polycystic ovary syndrome	0.0159	0.0431	CcSEcCtD
Ethosuximide—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.0146	0.0396	CcSEcCtD
Ethosuximide—Drowsiness—Metformin—polycystic ovary syndrome	0.0136	0.0368	CcSEcCtD
Ethosuximide—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.012	0.0325	CcSEcCtD
Ethosuximide—Eye disorder—Metformin—polycystic ovary syndrome	0.0114	0.0309	CcSEcCtD
Ethosuximide—Immune system disorder—Metformin—polycystic ovary syndrome	0.011	0.0299	CcSEcCtD
Ethosuximide—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.011	0.0298	CcSEcCtD
Ethosuximide—Malnutrition—Metformin—polycystic ovary syndrome	0.0106	0.0288	CcSEcCtD
Ethosuximide—Muscle spasms—Metformin—polycystic ovary syndrome	0.0102	0.0277	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00897	0.0243	CcSEcCtD
Ethosuximide—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00849	0.023	CcSEcCtD
Ethosuximide—Skin disorder—Metformin—polycystic ovary syndrome	0.00841	0.0228	CcSEcCtD
Ethosuximide—Anorexia—Metformin—polycystic ovary syndrome	0.00825	0.0224	CcSEcCtD
Ethosuximide—Somnolence—Metformin—polycystic ovary syndrome	0.0077	0.0209	CcSEcCtD
Ethosuximide—Decreased appetite—Metformin—polycystic ovary syndrome	0.00752	0.0204	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00747	0.0203	CcSEcCtD
Ethosuximide—Fatigue—Metformin—polycystic ovary syndrome	0.00746	0.0203	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00708	0.0192	CcSEcCtD
Ethosuximide—Urticaria—Metformin—polycystic ovary syndrome	0.00688	0.0187	CcSEcCtD
Ethosuximide—Abdominal pain—Metformin—polycystic ovary syndrome	0.00684	0.0186	CcSEcCtD
Ethosuximide—Asthenia—Metformin—polycystic ovary syndrome	0.00621	0.0169	CcSEcCtD
Ethosuximide—Diarrhoea—Metformin—polycystic ovary syndrome	0.00592	0.0161	CcSEcCtD
Ethosuximide—Dizziness—Metformin—polycystic ovary syndrome	0.00572	0.0155	CcSEcCtD
Ethosuximide—Vomiting—Metformin—polycystic ovary syndrome	0.0055	0.0149	CcSEcCtD
Ethosuximide—Rash—Metformin—polycystic ovary syndrome	0.00546	0.0148	CcSEcCtD
Ethosuximide—Dermatitis—Metformin—polycystic ovary syndrome	0.00545	0.0148	CcSEcCtD
Ethosuximide—Headache—Metformin—polycystic ovary syndrome	0.00542	0.0147	CcSEcCtD
Ethosuximide—Nausea—Metformin—polycystic ovary syndrome	0.00514	0.014	CcSEcCtD
Ethosuximide—CYP3A4—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.00202	0.0032	CbGpPWpGaD
Ethosuximide—CYP3A7—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.00202	0.0032	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—ISYNA1—polycystic ovary syndrome	0.002	0.00316	CbGpPWpGaD
Ethosuximide—CYP3A43—Biological oxidations—POMC—polycystic ovary syndrome	0.00199	0.00315	CbGpPWpGaD
Ethosuximide—CYP3A4—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.00195	0.00308	CbGpPWpGaD
Ethosuximide—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—polycystic ovary syndrome	0.00187	0.00296	CbGpPWpGaD
Ethosuximide—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.00186	0.00295	CbGpPWpGaD
Ethosuximide—CYP2E1—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00182	0.00288	CbGpPWpGaD
Ethosuximide—CYP3A5—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00182	0.00288	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—DLG4—polycystic ovary syndrome	0.00182	0.00287	CbGpPWpGaD
Ethosuximide—CYP3A7—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.00182	0.00287	CbGpPWpGaD
Ethosuximide—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.00181	0.00287	CbGpPWpGaD
Ethosuximide—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.00181	0.00286	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.0018	0.00285	CbGpPWpGaD
Ethosuximide—CYP3A7—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.00179	0.00283	CbGpPWpGaD
Ethosuximide—CYP2E1—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.00179	0.00283	CbGpPWpGaD
Ethosuximide—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.00178	0.00282	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.0017	0.00269	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—AKR1C2—polycystic ovary syndrome	0.0017	0.00269	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—TEAD2—polycystic ovary syndrome	0.0017	0.00269	CbGpPWpGaD
Ethosuximide—CYP3A7—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.00169	0.00268	CbGpPWpGaD
Ethosuximide—CYP3A7—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00169	0.00267	CbGpPWpGaD
Ethosuximide—CYP3A7—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.00166	0.00264	CbGpPWpGaD
Ethosuximide—CYP2E1—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.00159	0.00252	CbGpPWpGaD
Ethosuximide—CYP3A5—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.00159	0.00251	CbGpPWpGaD
Ethosuximide—CYP3A7—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.00151	0.00239	CbGpPWpGaD
Ethosuximide—CYP2E1—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.00148	0.00235	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.00148	0.00235	CbGpPWpGaD
Ethosuximide—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.00147	0.00232	CbGpPWpGaD
Ethosuximide—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.00147	0.00232	CbGpPWpGaD
Ethosuximide—CYP2E1—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.00146	0.00232	CbGpPWpGaD
Ethosuximide—CYP3A5—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.00146	0.00231	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PNPLA2—polycystic ovary syndrome	0.00142	0.00226	CbGpPWpGaD
Ethosuximide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.00142	0.00224	CbGpPWpGaD
Ethosuximide—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.0014	0.00221	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—NCOR1—polycystic ovary syndrome	0.00136	0.00215	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—SRD5A1—polycystic ovary syndrome	0.00135	0.00214	CbGpPWpGaD
Ethosuximide—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.00135	0.00214	CbGpPWpGaD
Ethosuximide—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.00135	0.00213	CbGpPWpGaD
Ethosuximide—CYP3A7—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.00134	0.00211	CbGpPWpGaD
Ethosuximide—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.00133	0.0021	CbGpPWpGaD
Ethosuximide—CYP3A7—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.00132	0.00209	CbGpPWpGaD
Ethosuximide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.00132	0.00209	CbGpPWpGaD
Ethosuximide—CYP2E1—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.00131	0.00208	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.00131	0.00208	CbGpPWpGaD
Ethosuximide—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.0013	0.00206	CbGpPWpGaD
Ethosuximide—CYP2E1—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.0013	0.00205	CbGpPWpGaD
Ethosuximide—CYP3A5—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.00129	0.00205	CbGpPWpGaD
Ethosuximide—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.00129	0.00204	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—STAR—polycystic ovary syndrome	0.00129	0.00204	CbGpPWpGaD
Ethosuximide—CYP2E1—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.00122	0.00194	CbGpPWpGaD
Ethosuximide—CYP2E1—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00122	0.00194	CbGpPWpGaD
Ethosuximide—CYP3A5—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.00122	0.00193	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00122	0.00193	CbGpPWpGaD
Ethosuximide—CYP2E1—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.00121	0.00191	CbGpPWpGaD
Ethosuximide—CYP3A5—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.0012	0.0019	CbGpPWpGaD
Ethosuximide—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.00115	0.00182	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—HMMR—polycystic ovary syndrome	0.00115	0.00182	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—LEP—polycystic ovary syndrome	0.00112	0.00177	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—HSD3B1—polycystic ovary syndrome	0.0011	0.00173	CbGpPWpGaD
Ethosuximide—CYP2E1—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.00109	0.00173	CbGpPWpGaD
Ethosuximide—CYP3A5—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.00109	0.00173	CbGpPWpGaD
Ethosuximide—CYP3A7—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.00108	0.0017	CbGpPWpGaD
Ethosuximide—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.00107	0.00169	CbGpPWpGaD
Ethosuximide—CYP3A7—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.00106	0.00168	CbGpPWpGaD
Ethosuximide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.00104	0.00165	CbGpPWpGaD
Ethosuximide—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.00104	0.00165	CbGpPWpGaD
Ethosuximide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.00103	0.00163	CbGpPWpGaD
Ethosuximide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.001	0.00158	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—LHB—polycystic ovary syndrome	0.000999	0.00158	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—HSD3B2—polycystic ovary syndrome	0.000976	0.00155	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—PPARG—polycystic ovary syndrome	0.000975	0.00154	CbGpPWpGaD
Ethosuximide—CYP2E1—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000967	0.00153	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000965	0.00153	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—INS—polycystic ovary syndrome	0.000956	0.00151	CbGpPWpGaD
Ethosuximide—CYP2E1—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000954	0.00151	CbGpPWpGaD
Ethosuximide—CYP3A5—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000952	0.00151	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—NMNAT3—polycystic ovary syndrome	0.000947	0.0015	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—AKR1C1—polycystic ovary syndrome	0.000946	0.0015	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—AKT2—polycystic ovary syndrome	0.000924	0.00146	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—SULT2A1—polycystic ovary syndrome	0.00087	0.00138	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—LPCAT2—polycystic ovary syndrome	0.000866	0.00137	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—SUOX—polycystic ovary syndrome	0.000866	0.00137	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—VEGFA—polycystic ovary syndrome	0.000846	0.00134	CbGpPWpGaD
Ethosuximide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000845	0.00134	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—RRM2—polycystic ovary syndrome	0.000843	0.00133	CbGpPWpGaD
Ethosuximide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.00084	0.00133	CbGpPWpGaD
Ethosuximide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000829	0.00131	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—YAP1—polycystic ovary syndrome	0.000812	0.00129	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ISYNA1—polycystic ovary syndrome	0.000805	0.00127	CbGpPWpGaD
Ethosuximide—CYP3A7—Biological oxidations—POMC—polycystic ovary syndrome	0.000803	0.00127	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—NAMPT—polycystic ovary syndrome	0.00078	0.00124	CbGpPWpGaD
Ethosuximide—CYP2E1—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.00078	0.00123	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000778	0.00123	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—CYP11A1—polycystic ovary syndrome	0.000771	0.00122	CbGpPWpGaD
Ethosuximide—CYP2E1—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000769	0.00122	CbGpPWpGaD
Ethosuximide—CYP3A5—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000768	0.00122	CbGpPWpGaD
Ethosuximide—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000738	0.00117	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—AKR1C3—polycystic ovary syndrome	0.000728	0.00115	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—CYP17A1—polycystic ovary syndrome	0.000717	0.00113	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000689	0.00109	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—NMNAT3—polycystic ovary syndrome	0.000686	0.00109	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—TEAD2—polycystic ovary syndrome	0.000685	0.00108	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—AKR1C2—polycystic ovary syndrome	0.000685	0.00108	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—NMNAT3—polycystic ovary syndrome	0.000685	0.00108	CbGpPWpGaD
Ethosuximide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000681	0.00108	CbGpPWpGaD
Ethosuximide—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000679	0.00108	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—LPCAT2—polycystic ovary syndrome	0.000627	0.000993	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—SUOX—polycystic ovary syndrome	0.000627	0.000993	CbGpPWpGaD
Ethosuximide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000626	0.000992	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—LPCAT2—polycystic ovary syndrome	0.000626	0.000991	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—SUOX—polycystic ovary syndrome	0.000626	0.000991	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—TH—polycystic ovary syndrome	0.00062	0.000982	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.00061	0.000966	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000604	0.000956	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—SLC2A4—polycystic ovary syndrome	0.000603	0.000955	CbGpPWpGaD
Ethosuximide—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000602	0.000953	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—IL6—polycystic ovary syndrome	0.000585	0.000927	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ISYNA1—polycystic ovary syndrome	0.000583	0.000923	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ISYNA1—polycystic ovary syndrome	0.000582	0.000921	CbGpPWpGaD
Ethosuximide—CYP2E1—Biological oxidations—POMC—polycystic ovary syndrome	0.000581	0.00092	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—POMC—polycystic ovary syndrome	0.00058	0.000919	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PNPLA2—polycystic ovary syndrome	0.000574	0.000908	CbGpPWpGaD
Ethosuximide—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000568	0.0009	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000567	0.000898	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—CYP19A1—polycystic ovary syndrome	0.000567	0.000898	CbGpPWpGaD
Ethosuximide—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000559	0.000886	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—SRD5A1—polycystic ovary syndrome	0.000544	0.000861	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—STAR—polycystic ovary syndrome	0.000519	0.000821	CbGpPWpGaD
Ethosuximide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000508	0.000804	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—GNAS—polycystic ovary syndrome	0.000506	0.000801	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000496	0.000785	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—TEAD2—polycystic ovary syndrome	0.000496	0.000785	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—AKR1C2—polycystic ovary syndrome	0.000495	0.000783	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—TEAD2—polycystic ovary syndrome	0.000495	0.000783	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—NCOR1—polycystic ovary syndrome	0.000482	0.000763	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—HMMR—polycystic ovary syndrome	0.000462	0.000732	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—CYP1A1—polycystic ovary syndrome	0.000457	0.000724	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000449	0.000711	CbGpPWpGaD
Ethosuximide—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000443	0.000701	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—HSD3B1—polycystic ovary syndrome	0.000441	0.000698	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—MTHFR—polycystic ovary syndrome	0.000426	0.000675	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—IL6—polycystic ovary syndrome	0.000418	0.000661	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000416	0.000658	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PNPLA2—polycystic ovary syndrome	0.000415	0.000657	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—LHB—polycystic ovary syndrome	0.000402	0.000637	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000394	0.000624	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—HSD3B2—polycystic ovary syndrome	0.000393	0.000623	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—SRD5A1—polycystic ovary syndrome	0.000393	0.000622	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—AKR1C1—polycystic ovary syndrome	0.000381	0.000603	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—STAR—polycystic ovary syndrome	0.000376	0.000595	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—STAR—polycystic ovary syndrome	0.000375	0.000594	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000362	0.000573	CbGpPWpGaD
Ethosuximide—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000357	0.000565	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—SULT2A1—polycystic ovary syndrome	0.00035	0.000555	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PPARG—polycystic ovary syndrome	0.000346	0.000547	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—POMC—polycystic ovary syndrome	0.000341	0.00054	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—RRM2—polycystic ovary syndrome	0.000339	0.000537	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—INS—polycystic ovary syndrome	0.000339	0.000537	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—HMMR—polycystic ovary syndrome	0.000335	0.00053	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—HMMR—polycystic ovary syndrome	0.000334	0.000529	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—YAP1—polycystic ovary syndrome	0.000327	0.000518	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—HSD3B1—polycystic ovary syndrome	0.00032	0.000506	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—HSD3B1—polycystic ovary syndrome	0.000319	0.000505	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000318	0.000504	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—NAMPT—polycystic ovary syndrome	0.000314	0.000498	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CYP11A1—polycystic ovary syndrome	0.00031	0.000491	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—AKR1C3—polycystic ovary syndrome	0.000293	0.000464	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—LHB—polycystic ovary syndrome	0.000291	0.000461	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000291	0.000461	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000291	0.000461	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—LHB—polycystic ovary syndrome	0.000291	0.00046	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CYP17A1—polycystic ovary syndrome	0.000289	0.000457	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000285	0.000451	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—HSD3B2—polycystic ovary syndrome	0.000284	0.00045	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000276	0.000437	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—AKR1C1—polycystic ovary syndrome	0.000275	0.000436	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000271	0.000428	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.00027	0.000427	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000254	0.000402	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—SULT2A1—polycystic ovary syndrome	0.000253	0.000401	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—TH—polycystic ovary syndrome	0.00025	0.000395	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—RRM2—polycystic ovary syndrome	0.000246	0.000389	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—RRM2—polycystic ovary syndrome	0.000245	0.000388	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—SLC2A4—polycystic ovary syndrome	0.000243	0.000385	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—YAP1—polycystic ovary syndrome	0.000237	0.000375	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—YAP1—polycystic ovary syndrome	0.000237	0.000374	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.00023	0.000364	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.00023	0.000364	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CYP19A1—polycystic ovary syndrome	0.000228	0.000362	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—NAMPT—polycystic ovary syndrome	0.000228	0.00036	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—NAMPT—polycystic ovary syndrome	0.000227	0.00036	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000225	0.000356	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CYP11A1—polycystic ovary syndrome	0.000224	0.000355	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000212	0.000336	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—AKR1C3—polycystic ovary syndrome	0.000212	0.000336	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000209	0.000331	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CYP17A1—polycystic ovary syndrome	0.000209	0.00033	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GNAS—polycystic ovary syndrome	0.000204	0.000323	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—NCOR1—polycystic ovary syndrome	0.000194	0.000307	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000193	0.000305	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CYP1A1—polycystic ovary syndrome	0.000184	0.000291	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	0.000183	0.000289	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—TH—polycystic ovary syndrome	0.000181	0.000286	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—TH—polycystic ovary syndrome	0.000181	0.000286	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000176	0.000279	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—SLC2A4—polycystic ovary syndrome	0.000176	0.000278	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	0.000174	0.000276	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—MTHFR—polycystic ovary syndrome	0.000172	0.000272	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CYP19A1—polycystic ovary syndrome	0.000165	0.000262	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CYP19A1—polycystic ovary syndrome	0.000165	0.000261	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	0.000155	0.000246	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	0.000148	0.000235	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GNAS—polycystic ovary syndrome	0.000148	0.000234	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GNAS—polycystic ovary syndrome	0.000147	0.000233	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—NCOR1—polycystic ovary syndrome	0.000141	0.000223	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—NCOR1—polycystic ovary syndrome	0.00014	0.000222	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PPARG—polycystic ovary syndrome	0.000139	0.00022	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—POMC—polycystic ovary syndrome	0.000137	0.000217	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—INS—polycystic ovary syndrome	0.000137	0.000216	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	0.000135	0.000214	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CYP1A1—polycystic ovary syndrome	0.000133	0.000211	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CYP1A1—polycystic ovary syndrome	0.000133	0.000211	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	0.000132	0.000209	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	0.000128	0.000203	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—MTHFR—polycystic ovary syndrome	0.000124	0.000197	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—MTHFR—polycystic ovary syndrome	0.000124	0.000196	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	0.000118	0.000186	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	0.000114	0.000181	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	0.00011	0.000174	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	0.000106	0.000167	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	0.000104	0.000165	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PPARG—polycystic ovary syndrome	0.000101	0.00016	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PPARG—polycystic ovary syndrome	0.000101	0.000159	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—POMC—polycystic ovary syndrome	9.94e-05	0.000157	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—POMC—polycystic ovary syndrome	9.92e-05	0.000157	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—INS—polycystic ovary syndrome	9.89e-05	0.000157	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—INS—polycystic ovary syndrome	9.87e-05	0.000156	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	9.85e-05	0.000156	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	9.7e-05	0.000154	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—TH—polycystic ovary syndrome	8.39e-05	0.000133	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	8.16e-05	0.000129	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	7.68e-05	0.000122	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	6.85e-05	0.000108	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	6.53e-05	0.000103	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	6.19e-05	9.8e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	5.77e-05	9.13e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	4.68e-05	7.4e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	4.61e-05	7.3e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—INS—polycystic ovary syndrome	4.59e-05	7.26e-05	CbGpPWpGaD
